Paniti Sukumvanich, L. Doug Case, Kimberly Van Zee, S. Eva Singletary, Electra D. Paskett, Jeanne A. Petrek, Elizabeth Naftalis and Michelle J. Naughton Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment Cancer 116
Version of Record online: 9 APR 2010 | DOI: 10.1002/cncr.25106
A considerable proportion of women treated with chemotherapy will experience periods of chemotherapy-induced amenorrhea, but many will resume bleeding. Newer treatment regimens such as doxorubicin, cyclophosphamide, and paclitaxel appear to have a higher resumption of bleeding compared with the combination of cyclophosphamide, methotrexate, and 5-fluorouracil.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field